MS Stem Cell Transplant

Autologous Haematopoietic Stem Cell Transplant

Also known as AHSCT or HSCT, this treatment reboots the immune system to halt the progression of MS.

Join us on 21st November for a live webinar featuring Dr Majid Kazmi, Consultant Haematologist and Dr Ben Turner, Consultant Neurologist. Learn about stem cell treatment options for multiple sclerosis. Register now for free.

HSCT therapy for MS

For those with Multiple Sclerosis in whom first line therapies have not worked, HSCT offers the most exciting treatment yet – a true breakthrough in the fight against this debilitating condition.

HSCT aims to ‘reboot’ the immune system, to stop it attacking itself and repair any existing damage. It uses chemotherapy to wipe out harmful cells and then reset the immune system using stem cells found in your bone marrow, known as haematopoietic stem cells. Watch our animation to follow the key stages of treatment.

Suitability for HSCT

Stem cell transplantation treatment of this kind is a highly specialised, intensive procedure. Hear Dr Ben Turner, Consultant Neurologist discuss the suitability of patients undergoing this treatment and why they must meet the following criteria:

If you have primary, progressive MS (PPMS), you need a lumbar puncture with oligoclonal bands.
If you have relapsing remitting MS, you have to fulfil the McDonald criteria.
Be between the ages of 18 and 65.
Received a diagnosis of MS within the last 15 years.
Have a mobility score between 0 – 6.5 (walking with bilateral assistance such as two sticks or a rollator frame).

HSCT at HCA UK

London Bridge Hospital is ideally placed to offer this state-of-the-art therapy, led by one of the pioneers in HSCT for autoimmune disease in the UK, Dr Majid Kazmi, Consultant Haematologist.

Providing this treatment requires the highest levels of experience, clinical quality, appropriate back-up expertise and patient support through the prolonged recovery period.

A JACIE accredited centre

Set in an accredited clinical environment and in the comfort of first-class facilities, HSCT at London Bridge Hospital is primed to transform the lives of patients with MS.

Having carried out over 200 transplants across London’s teaching hospitals, the team have vast experience in this game-changing therapy and include specialist HSCT neurologists and haematologists, clinical nurse specialists, pharmacists, physiotherapists, occupational therapists and dietitians.

How to get referred

Your consultant neurologist or GP should provide the following information:

Documented diagnosis of Multiple Sclerosis by a neurologist with the date of the diagnosis.
A record of the ability to walk 20 metres without resting or needing, at most, bilateral assistance with two sticks or a rollator frame.
If you have relapsing MS, documentation to show that treatment with one of the high-efficacy disease modifying drugs has been unsuccessful.
If no high-efficacy DMT has been tried, the reason for moving directly to HSCT needs to be recorded.
MRI scans showing activity within the last 12 months compared to a comparative scan that was done in the previous two to three years. The radiology reports from both time frames should be included with the written referral.

This information will form the basis for an initial consultation with your assigned neurologist, Dr Ben Turner, Dr Eli Silber or Dr Richard Nicholas.

Call 020 3993 8039 to arrange an appointment

Haematopoietic Stem Cell Transplantation (HSCT) for multiple sclerosis (MS)

Hear Reema’s story

Reema, 29, was diagnosed with multiple sclerosis (MS) in 2015. She booked a consultation with Dr Majid Kazmi, Consultant Haematologist and he put her forward for Haematopoietic Stem Cell Transplantation (HSCT) at London Bridge Hospital. Reema looks back at her experience and shares her story.